KYNB
Kyntra Bio, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$8.55
+0.71%Aug 31, 2026, 20:05 UTC
Kyntra Bio signed an amendment and restatement of its royalty financing agreement with NQ Project Phoebus, L.P., materially reducing its payment obligations in exchange for an accelerated upfront payment.
Source:Aug 13, 2026, 20:02 UTC
Kyntra Bio reported its financial results for the second quarter of 2026.